Life Sciences

As costs escalate, demographics shift and regulatory complexities increase, life sciences companies can’t hold on to the past — new approaches are needed to deliver personalized care and better health outcomes faster and with greater efficiency.


34,500+
life sciences practitioners worldwide are ready to help clients today.

8,400+
global life sciences clients trust EY to help them demonstrate greater value.

US$1b+
annual investment in data, tech and AI to solve complex client challenges.

Solving your complex challenges

CHALLENGE

Allocate capital effectively to generate growth, improve returns and achieve long-term objectives.

Companies need acquisitions and alliances to build their portfolios. With heavy competition for assets across a widening frontier of innovation, companies need to partner more effectively across a wider range of both technologies and geographies.


HOW EY CAN HELP

EY helps life sciences’ clients partner across the innovation ecosystem to accelerate growth, enhance agility, reduce time-to-market and scale impactful innovations.

  • Value creation: Helping clients refine their growth strategy, perform deal sourcing, conduct diligence and valuation, and implement M&A integration.

  • Deep insight into portfolio management: Facilitating strategic portfolio management and better divestments that help clients improve value from the sale of an entire company, carve-out, spin-off or joint venture.

  • Financial performance transformation: Supporting clients with their business challenges from every angle and helping them rapidly create, preserve and recover value.

FEATURED

Hyperlapse timelapse of automated train in Tokyo, Japan futuristic transportation technology concept

EY Firepower report: life sciences dealmaking – trends in 2026
Dealmaking will continue to be driven not by market variations but by strategic fundamentals.

CHALLENGE

Improve operational efficiency by taking costs out to fund growth

Reducing costs and optimizing operations remains a top priority, across back-office functions from Global Business Services (GBS) to risk, regulatory and other processes. Agentic AI has emerged as a key lever for streamlining operations and protecting margins.


HOW EY CAN HELP

EY supports life sciences clients in achieving operational efficiency by helping them to optimize end-to-end value chain to control costs, ensure product/service quality and adherence to regulations, and fund innovation.

  • Redesign operating models for agility: Helping clients rethink internal and external processes to drive speed, resilience and customer-centricity.

  • Implement digital performance frameworks: Offering real-time data monitoring, cloud solutions and process integration to enhance manufacturing reliability and productivity. A digital-first approach supports cross-functional collaboration and long-term operational resiliency.

  • Drive holistic transformation for sustainable success: Creating siloed operations and legacy systems with integrated strategies that align with evolving stakeholder expectations and regulatory demands.

  • Enable talent for operational agility: Equipping teams with the right tools, training and upskilling programs to foster a culture of continuous improvement.

FEATURED

Female scientist discussing results of experiment with male colleague

How life sciences legal teams prepare for a technology-driven future
Advances in healthcare technology create new data flows for life sciences companies, shifting the landscape for legal departments.

CHALLENGE

Configure adaptive manufacturing and supply chains

The industry’s manufacturing model faces onshoring pressures, soaring logistical costs, supply vulnerabilities and counterfeiting challenges. Companies need a smarter, AI-assisted digital manufacturing model that can ensure supply chain security, visibility, agility and operational resilience.


HOW EY CAN HELP

EY helps life sciences clients improve supply and demand synchronization via advanced analytics and the creation of new adaptive manufacturing capability.

  • Smart manufacturing for resilient operations: Supporting clients in digitizing and automating core processes to improve quality, reducing costs and accelerating time-to-market.

  • Predictive demand forecasting: Leveraging AI and advanced analytics to synchronize supply and demand, optimize inventory and improve production planning.

  • AI-powered production transformation: Applying agentic AI, virtual twin technology and predictive analytics to optimize batch review, yield and quality control.

  • Collaborative digital ecosystems: Building agile, cross-functional ecosystems that connect teams, data and systems across the value chain.

  • Regulatory-ready automation: Deploying automation and digital tools that streamline compliance and reduce risk.

FEATURED

How AI is supporting pharmaceutical manufacturing and supply chain

In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O’Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.

CHALLENGE

Use data more effectively to deliver innovation to patients faster

With development delays, failing launches and payer pushback, companies must bring commercial excellence into the end-to-end product lifecycle: accelerating from research and development to commercialization, leveraging next-generation Customer Relationship Management (CRM), and measuring real-world outcomes to support reimbursement.


HOW EY CAN HELP

EY helps life sciences implement new technologies and AI-powered solutions that enable holistic, high-quality care, products, services, and support digitized service models and operations.

  • Accelerated launch strategies for market impact: Empowering biopharma teams to plan, execute and measure product launches with precision. Integrated strategy, operations and technology deliver faster, simpler and more successful launches.

  • Behavioral benchmarking for salesforce excellence: Using data-led insights to optimize field-force performance, proven commercial behaviors are embedded in leaders and frontline teams to improve engagement and outcomes.

  • Integrated CRM and regulatory platforms: Modernizing CRM and streamlining regulatory processes through unified platform adoption.

  • Product Life Cycle and Portfolio management: Supporting clients in managing product portfolios and lifecycle strategies to improve commercial potential and align with evolving therapeutic priorities.

FEATURED

Boy throws a toy airplane in the summer at sunset

How biopharma can get the right mix of people and tech for launch success
Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed.

Rapid developments in the pharmaceutical industry require the adaptation of EU legislations.

Find out at what the upcoming regulatory change means for Swiss Life Sciences Companies and what effects are to be expected.

Whitepaper: Evidence generation in medical affairs

Evidence generation, a case for change in value demonstration and a key to unlock the future of the medical affairs organization.

Silhouette Business Travellers

EY Partner Ecosystem

EY harnesses a connected ecosystem of strategic alliances and partnerships to co-create value and deliver comprehensive technology solutions and business outcomes for our clients.

Our latest thinking

EY Firepower report: life sciences dealmaking – trends in 2026

Learn how life sciences organizations can accelerate dealmaking strategies to succeed.

    EY Biotech Beyond Borders Report 2025

    Find out how biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape.

    EY Pulse of the MedTech Industry Report 2025

    Learn how MedTech companies are reigniting growth and expanding markets, with the industry's annual revenue growing for the seventh straight year, reaching almost US$600 billion for the first time.


    Shape the future with confidence

    Get in touch with us to learn more about how we can help you to confidently reimagine your role in an evolving energy ecosystem.

    Explore related sector pages:   Consumer Products  |  Health   |   Retail